Corbion N.V. : Back on a long term support level
Entry price | Target | Stop-loss | Potential |
---|
€38 |
€41.3 |
€35.85 |
+8.68% |
---|
Corbion N.V. shares reflect an interesting technical chart pattern from a medium term view In fact, the support at 36.24 EUR represents an important technical support area based on weekly price data that could limit downward movements by the stock.
Summary● The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths● Over the last twelve months, the sales forecast has been frequently revised upwards.
● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
● Analyst opinion has improved significantly over the past four months.
Weaknesses● With a 2021 P/E ratio at 28.69 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
● In relation to the value of its tangible assets, the company's valuation appears relatively high.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.